Non-Coding RNAs in Kidney Diseases: The Long and Short of Them
Autor
Moreno, Juan Antonio
Hamza, Eya
Guerrero-Hue, Melania
Rayego-Mateos, Sandra
García-Caballero, Cristina
Vallejo-Mudarra, Mercedes
Metzinger, Laurent
Metzinger-Le Meuth, Valérie
Editor
MDPIFecha
2021Materia
Non-coding RNAMicroRNAs
Long non-coding RNA
Chronic kidney disease
Acute kidney disease
IgA nephropathy
Gene regulation
METS:
Mostrar el registro METSPREMIS:
Mostrar el registro PREMISMetadatos
Mostrar el registro completo del ítemResumen
Recent progress in genomic research has highlighted the genome to be much more transcribed than expected. The formerly so-called junk DNA encodes a miscellaneous group of largely unknown RNA transcripts, which contain the long non-coding RNAs (lncRNAs) family. lncRNAs are instrumental in gene regulation. Moreover, understanding their biological roles in the physiopathology of many diseases, including renal, is a new challenge. lncRNAs regulate the effects of microRNAs (miRNA) on mRNA expression. Understanding the complex crosstalk between lncRNA–miRNA–mRNA is one of the main challenges of modern molecular biology. This review aims to summarize the role of lncRNA on kidney diseases, the molecular mechanisms involved, and their function as emerging prognostic biomarkers for both acute and chronic kidney diseases. Finally, we will also outline new therapeutic opportunities to diminish renal injury by targeting lncRNA with antisense oligonucleotides.